In this study, we show that RY-2f induces G2/M cell cycle arrest with down-regulation of cyclin A and CDK2, and up-regulation of p21 (Figure 2C), indicating that cancer cells may exit from G2 phase and enter M phase in response to RY-2f treatment. This evidence concerns the gene CDKN1A and cancer.